Bleeding Disorder
29
12
13
14
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 29 trials
100.0%
+13.5% vs benchmark
7%
2 trials in Phase 3/4
21%
3 of 14 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 14 completed trials
Clinical Trials (29)
The Bleeding Assessment Tool (BAT)
Bleeding of Unknown Cause: a Swiss Case-control Study
ATHNdataset Registry
Hemophilia A Research Program
National Longitudinal Cohort of Hematological Diseases
Examining the Experiences of Children With Blood Disorders
Recombinant vWF Concentrate and ECMO
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Heavy Menstrual Bleeding Progestin Treatment in Bleeding Disorders Study
Operator and Patient Acceptance of Radiofrequency Cautery of the Biopsy Track During Percutaneous Liver, Kidney or Spleen Biopsy Procedures.
Early Genomic Testing for Inherited Bleeding Disorders
Adjusted Fibrinogen Replacement Strategy
Personalized ViscoElastic Testing-guided Bleeding Management In Liver Surgery, Neurosurgery and Obstetrics
Role of Thromboelastography in Septic Shock
Hormonal Management of Heavy Menstrual Bleeding in Adolescents
Longitudinal Cohort of Thrombosis and Hemostasis Diseases
Extracorporeal Life Support and Modification of Hemostasis
European Rare Blood Disorders Platform (ENROL)
Protection of Knee Joints in Bleeding Disorder Patients
Characterizing the Impact and Treatment of Reproductive Tract Bleeding on Women and Post-menarchal Girls With Bleeding Disorders